These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 8692734)

  • 41. Influence of the timing of ultrasound application on the penetration of corticosteroids.
    Clijsen R; Baeyens JP; Barel AO; Clarys P
    Skin Res Technol; 2013 Feb; 19(1):e279-82. PubMed ID: 22712560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-frequency sonophoresis: a review.
    Mitragotri S; Kost J
    Adv Drug Deliv Rev; 2004 Mar; 56(5):589-601. PubMed ID: 15019748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Applicability and safety of dual-frequency ultrasonic treatment for the transdermal delivery of drugs.
    Schoellhammer CM; Srinivasan S; Barman R; Mo SH; Polat BE; Langer R; Blankschtein D
    J Control Release; 2015 Mar; 202():93-100. PubMed ID: 25662228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of peptide dendrimers and sonophoresis on the transdermal delivery of ketoprofen.
    Manikkath J; Hegde AR; Kalthur G; Parekh HS; Mutalik S
    Int J Pharm; 2017 Apr; 521(1-2):110-119. PubMed ID: 28163223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skin permeability enhancement by low frequency sonophoresis: lipid extraction and transport pathways.
    Alvarez-Román R; Merino G; Kalia YN; Naik A; Guy RH
    J Pharm Sci; 2003 Jun; 92(6):1138-46. PubMed ID: 12761803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Porous resins as a cavitation enhancer for low-frequency sonophoresis.
    Terahara T; Mitragotri S; Langer R
    J Pharm Sci; 2002 Mar; 91(3):753-9. PubMed ID: 11920760
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synergistic effect of low-frequency ultrasound and surfactants on skin permeability.
    Tezel A; Sens A; Tuchscherer J; Mitragotri S
    J Pharm Sci; 2002 Jan; 91(1):91-100. PubMed ID: 11782900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synergistic effects of chemical enhancers and therapeutic ultrasound on transdermal drug delivery.
    Johnson ME; Mitragotri S; Patel A; Blankschtein D; Langer R
    J Pharm Sci; 1996 Jul; 85(7):670-9. PubMed ID: 8818988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A combined approach of chemical enhancers and sonophoresis for the transdermal delivery of tizanidine hydrochloride.
    Mutalik S; Parekh HS; Davies NM; Udupa N
    Drug Deliv; 2009 Feb; 16(2):82-91. PubMed ID: 19267299
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transdermal extraction of interstitial fluid by low-frequency ultrasound quantified with 3H2O as a tracer molecule.
    Cantrell JT; McArthur MJ; Pishko MV
    J Pharm Sci; 2000 Sep; 89(9):1170-9. PubMed ID: 10944382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Low-frequency sonophoresis: application to the transdermal delivery of macromolecules and hydrophilic drugs.
    Polat BE; Blankschtein D; Langer R
    Expert Opin Drug Deliv; 2010 Dec; 7(12):1415-32. PubMed ID: 21118031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synergistic effect of enhancers for transdermal drug delivery.
    Mitragotri S
    Pharm Res; 2000 Nov; 17(11):1354-9. PubMed ID: 11205727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical, histologic, and electron microscopy study of skin exposed to low-frequency ultrasound.
    Boucaud A; Montharu J; Machet L; Arbeille B; Machet MC; Patat F; Vaillant L
    Anat Rec; 2001 Sep; 264(1):114-9. PubMed ID: 11505377
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synergistic effect of electric field and ultrasound on transdermal transport.
    Kost J; Pliquett U; Mitragotri S; Yamamoto A; Langer R; Weaver J
    Pharm Res; 1996 Apr; 13(4):633-8. PubMed ID: 8710759
    [No Abstract]   [Full Text] [Related]  

  • 55. Scanning electron microscopic evaluation of the skin surface after ultrasound exposure.
    Yamashita N; Tachibana K; Ogawa K; Tsujita N; Tomita A
    Anat Rec; 1997 Apr; 247(4):455-61. PubMed ID: 9096784
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of low frequency ultrasound on the in vitro percutaneous absorption of clobetasol 17-propionate.
    Fang J; Fang C; Sung KC; Chen H
    Int J Pharm; 1999 Nov; 191(1):33-42. PubMed ID: 10556738
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transdermal Delivery of Enfuvirtide in a Porcine Model Using a Low-Frequency, Low-Power Ultrasound Transducer Patch.
    Snook KA; Van Ess R; Werner JR; Clement RS; Ocon-Grove OM; Dodds JW; Ryan KJ; Acosta EP; Zurlo JJ; Mulvihill ML
    Ultrasound Med Biol; 2019 Feb; 45(2):513-525. PubMed ID: 30583819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of lipid bilayer alteration on transdermal delivery of a high-molecular-weight and lipophilic drug: studies with paclitaxel.
    Panchagnula R; Desu H; Jain A; Khandavilli S
    J Pharm Sci; 2004 Sep; 93(9):2177-83. PubMed ID: 15295779
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluorescein permeability and electrical resistance of human skin during low frequency ultrasound application.
    Cancel LM; Tarbell JM; Ben-Jebria A
    J Pharm Pharmacol; 2004 Sep; 56(9):1109-18. PubMed ID: 15324479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.